Webcasts & Presentations
Upcoming Events
| Date | Event Details | Remind me |
|---|---|---|
|
February 6, 2025 at 10:00 AM EST
|
Q4 2024 Earnings Call
|
|
|
May 1, 2025 at 10:00 AM EDT
|
Q1 2025 Earnings Call
|
|
|
August 7, 2025 at 10:00 AM EDT
|
Q2 2025 Earnings Call
|
|
|
October 30, 2025 at 10:00 AM EDT
|
Q3 2025 Earnings Call
|
Archived Events
| Date | Event Details |
|---|---|
|
October 30, 2024 at 10:00 AM EDT
|
Q3 2024 Earnings Call
Q3 2024 Lilly Press Release 205.2 KB
Q3 2024 Lilly Presentation 1.2 MB
Q3 2024 Financial Workbook 67.4 KB
|
|
September 5, 2024 at 7:45 AM EDT
|
Morgan Stanley 22nd Annual Global Healthcare Conference
Speaker: Jake Van Naarden, Executive Vice President, President of Lilly Oncology
|
|
August 8, 2024 at 10:00 AM EDT
|
Q2 2024 Earnings Call
Q2 2024 Lilly Press Release 407.7 KB
Q2 2024 Lilly Presentation 1.1 MB
Q2 2024 Financial Workbook 65.7 KB
|
|
June 10, 2024 at 4:00 PM EDT
|
Goldman Sachs 45th Annual Global Healthcare Conference
Speaker: Patrik Jonsson, Executive Vice President, President of Lilly Diabetes and Obesity and Lilly USA |
|
June 2, 2024 at 7:30 PM CDT
|
Lilly Oncology ASCO Investor Event
|
|
April 30, 2024 at 10:00 AM EDT
|
Q1 2024 Earnings Call
Q1 2024 Lilly Press Release 197 KB
Q1 2024 Lilly Presentation 1.2 MB
Q1 2024 Financial Workbook 61.4 KB
|
|
March 6, 2024 at 9:10 AM EST
|
Cowen's 44th Annual Health Care Conference
Speaker: Anat Ashkenazi, Executive Vice President and Chief Financial Officer
|
|
February 6, 2024 at 10:00 AM EST
|
Q4 2023 Earnings Call
Q4 2023 Lilly Press Release 212.1 KB
Q4 2023 Lilly Presentation 2.8 MB
Q4 2023 Financial Workbook 81.6 KB
|
|
January 9, 2024 at 2:15 PM PST
|
42nd Annual J.P. Morgan Healthcare Conference
Speaker: Dave Ricks, Chair and Chief Executive Officer |
|
November 28, 2023 at 3:50 PM EST
|
Evercore ISI HealthCONx Conference
Speaker: Dr. Dan Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, and President of Lilly Research Laboratories
|
|
November 8, 2023 at 3:00 PM EST
|
UBS Biopharma Conference 2023
Speaker: Patrik Jonsson, Executive Vice President, President of Lilly Immunology and Lilly USA, and Chief Customer Officer |
|
November 2, 2023 at 9:00 AM EDT
|
Q3 2023 Earnings Call
Q3 2023 Lilly Press Release 279 KB
Q3 2023 Lilly Presentation 1.6 MB
Q3 2023 Financial Workbook 102.9 KB
|
|
September 11, 2023 at 2:55 PM EDT
|
Morgan Stanley 21st Annual Global Healthcare Conference
Speaker: Dr. Dan Skovronsky, Executive Vice President, Chief Scientific and Medical Officer, and President of Lilly Research Laboratories
|
|
August 8, 2023 at 9:00 AM EDT
|
Q2 2023 Earnings Call
Q2 2023 Lilly Press Release 304.6 KB
Q2 2023 Lilly Presentation 10.2 MB
|
|
July 17, 2023 at 1:30 PM EDT
|
2023 AAIC Lilly Alzheimer’s Disease Update
|
|
July 17, 2023 at 10:15 AM EDT
|
Alzheimer's Association International Conference Scientific Presentation - Donanemab TRAILBLAZER-ALZ 2
|
|
June 12, 2023 at 4:20 PM EDT
|
Goldman Sachs 44th Annual Global Healthcare Conference
Speaker: Anat Ashkenazi, Executive Vice President and Chief Financial Officer
|
|
May 10, 2023 at 1:00 PM EDT
|
Bank of America Securities 2023 Healthcare Conference
Speaker: Patrik Jonsson, Senior Vice President, President of Lilly Immunology and Lilly USA, and Chief Customer Officer
|
|
April 27, 2023 at 10:00 AM EDT
|
Q1 2023 Earnings Call
Q1 2023 Lilly Press Release 254.7 KB
Q1 2023 Lilly Presentation 7.9 MB
Q1 2023 Financial Workbook 98.2 KB
|
